These findings support a model by which elevated CRIP1 actively promotes amyloid nucleation and aggregation within vessel walls, likely contributing to increased WMH, infarcts, and microbleeds observed by MRI, while reduced CRIP1 levels may confer resilience to such injury (Figure 7A). The gene discussed is CRIP1; the disease is infarction.